Australia Wants to Improve Generic Drug Authorizations

Drug Industry Daily
A A
Australia’s Therapeutic Goods Administration (TGA) is asking for feedback on changes it’s considering for its generic drug market authorization process — including the potential use of foreign reference products to show bioequivalence.

To View This Article:

Login

Subscribe To Drug Industry Daily